ADAP Articles, Adaptimmune Therapeutics plc
home / stock / adap / adap articles
No one has written and article on Adaptimmune Therapeutics plc, stock symbol ADAP. Be the first to contribute and write an article.
Adaptimmune Therapeutics plc Company Name:
ADAP Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
Shares of the British cell therapy company Adaptimmune Therapeutics (NASDAQ: ADAP) are having one of their best days in several months today. Specifically, the biotech's stock is currently up by a respectable 7.72% as of 2:05 p.m. ET Monday. To put this move into the proper cont...
-
- Patients who responded to afami-cel had longer progression-free survival (median 58 weeks) compared to non-responders (median 12 weeks) - - Responses occurred across subgroups, with greater response rates associated with lower baseline tumor burden, fewer prior lines of therapy, and higher ...
-
Shares of Adaptimmune Therapeutics (NASDAQ: ADAP) , a clinical-stage biopharmaceutical company that specializes in T-cell therapies to treat cancer, jumped 13.4% on Tuesday. The company's shares are down more than 58% so far this year. The company reported positive proof-of-...